“Technology can be used to produce highly functional performance ingredients (e.g. foaming, gelling, emulsifying) that can be used as additives (and nutrients) in different food products to make appealing and stable food items. This is what we typically call acellular component production technology. Examples of these products are egg and dairy proteins. Furthermore, nutritionally important components (e.g. proteins, lipids, bioactive) can be produced to complement the nutritional requirements of special diets for instance. We can also produce proteins that are very sweet and can be used as sweeteners (by using plants containing highly sweet proteins). The sweet proteins may help us tackle health challenges related to sugar consumption.
In addition to the high-performance component production, cellular agriculture can be used to produce microbial biomass/cell mass that can be used as raw food materials (single cell proteins, cell cultures of meat and plant). These raw materials can be used for meat-like product formulation for example with Quorn being a commercial example. An interesting concept of single cell production is Solar Foods (a spin-off company of VTT) and their Solein product that is made by using solar power and CO2 as a carbon source. Generally, finding sustainable feedstock and energy sources for the cell factories is of course the most important. Solar Foods seems to be on the right track there.
Regarding the new food production concepts described above, they fall under the EU’s novel food regulation. This means they need to go through the EFSA evaluation process. However, as mentioned earlier, Perfect Day has launched an ice-cream with dairy proteins produced by microbes while Quorn is already on the market. In theory there should not be any critical obstacles that would stop the market entry as long as safety can be ensured.
Then again, when we start designing the perfect proteins (with a really high techno-functionality and the perfect nutritional quality for instance) and other components by genetic engineering, we are in a longer route and more specific safety considerations (e.g. allergenicity) should be included.
Could we remove the allergenic properties of some proteins? Probably. While the GMO discussion in the EU is ongoing and EU legislation is still under-developed, hopefully EFSA will be open-minded and will evaluate the newly emerging technologies from the point of view of their potential regarding sustainable food production.”